Ascrinvacumab (Anti-ACVRL1 / ALK-1)

Ask supplier a question | View on supplier's website

Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.

Supplier	Selleck Chemicals
Product #	A2594
Sku #	A2594-1mg*25
Pricing	1mg*25, $2370.00

Feedback